This interaction promotes tumor cell proliferation via the extracellular signal-regulated kinase (ERK), p38 MAPK, and NF-κB signaling pathways while also inhibiting CD8+ T cells and Tregs [223–225]. This evidence concerns the gene CD8A and neoplasm.